Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4,165 JPY | -1.28% | -0.64% | +2.74% |
06-11 | Takeda Issues New Shares, Disposes of Treasury Shares Under Long-term Incentive Plan for Employees | MT |
06-10 | Takeda Pharmaceutical Prices Second Hybrid Bonds for 460 Billion Yen | MT |
Sales 2024 | 4,264B 27.19B 2,126B | Sales 2025 * | 4,258B 27.15B 2,123B | Capitalization | 6,619B 42.21B 3,300B |
---|---|---|---|---|---|
Net income 2024 | 144B 919M 71.83B | Net income 2025 * | 112B 716M 56B | EV / Sales 2024 | 2.57 x |
Net Debt 2024 | 4,386B 27.97B 2,187B | Net Debt 2025 * | 4,189B 26.71B 2,088B | EV / Sales 2025 * | 2.54 x |
P/E ratio 2024 |
45.4
x | P/E ratio 2025 * |
59
x | Employees | 49,095 |
Yield 2024 |
4.49% | Yield 2025 * |
4.65% | Free-Float | 99.12% |
Latest transcript on Takeda Pharmaceutical Company Limited
1 day | -1.28% | ||
1 week | -0.64% | ||
Current month | -0.19% | ||
1 month | +0.87% | ||
3 months | -3.45% | ||
6 months | +1.34% | ||
Current year | +2.74% |
Managers | Title | Age | Since |
---|---|---|---|
Christophe Weber
CEO | Chief Executive Officer | 57 | 31/03/14 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 45 | 31/01/22 |
Mwana Lugogo
CMP | Compliance Officer | 54 | 31/12/11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 71 | 31/05/16 | |
Ian Clark
BRD | Director/Board Member | 62 | 31/12/18 |
Steven Gillis
BRD | Director/Board Member | 71 | 31/12/18 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
24.44% | 14 M€ | +11.40% | ||
3.80% | 1,476 M€ | +22.56% | ||
3.43% | 240 M€ | +19.42% | ||
3.26% | 58 M€ | +23.42% |
Date | Price | Change | Volume |
---|---|---|---|
12/06/24 | 4,165 | -1.28% | 3,282,500 |
11/06/24 | 4,219 | -0.52% | 2,688,400 |
10/06/24 | 4,241 | +0.21% | 2,236,500 |
07/06/24 | 4,232 | +0.69% | 3,194,100 |
06/06/24 | 4,203 | -0.28% | 2,385,000 |
Delayed Quote Japan Exchange, June 12, 2024 at 07:00 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.74% | 42.09B | |
+48.79% | 780B | |
+41.76% | 627B | |
+19.43% | 334B | |
+7.18% | 296B | |
+17.60% | 244B | |
-0.41% | 217B | |
+11.54% | 214B | |
+4.53% | 161B | |
-3.92% | 159B |
- Stock Market
- Equities
- 4502 Stock